The Uromigos Episode 81: Noah Hahn Discusses Front-Line Cisplatin-Ineligible PD-L1 Data from 361 and 130

Dr. Noah Hahn, medical oncologist at Johns Hopkins, discusses ASCO GU Symposium 2021 data on the cisplatin-ineligible PD-L1 positive population. These new data are important as it is the setting where these agents are currently recommended, but we have not seen the data in this specific subset until now.